The Sydney Angels Sidecar Fund 3 partners exclusively with Sydney Angels to co-invest with experienced active angels. The fund leverages over a decade of Sydney Angels' deal origination, evaluation and management expertise to access curated investment opportunities into high-growth early-stage private companies. So far, members have invested $41M in 91 deals, achieving six significant exits with returns up to 50x, including Clarity Pharmaceuticals. Over $5,000,000 raised to date. Join the waitlist for the Final Tranche! The fund has already deployed capital into its first three investments, iiShield, MaryTechnology & CrossCourtAI.
Fund highlights
- Fund Structure: The Fund is structured as a limited partnership that is conditionally registered as an Early Stage Venture Capital Limited Partnership. The minimum capital commitment is $25,000 which will be called in 5 equal annual instalments, with the first 20% required on application.
- Tax Concessions: Returns from the Fund are exempt from capital gains and income tax. In addition, investors receive a non-refundable tax offset of 10% of their upfront investment amount.
- Investment Objective: The Fund is targeting an annualised return of >20% over the life of the Fund by deploying the substantial experience of its own investment management team together with the Sydney Angels Committee and Sydney Angels’ members in making, building and realising seed, start-up and early expansion investments.
- Investment Strategy: The investment strategy of the Fund is to gain exposure to high quality early stage investment opportunities that have been selected, screened and invested in, by members of Sydney Angels
- Portfolio Size: The Fund expects to invest in approximately 25-35 early stage companies. The Fund plans to make initial and follow-on investments ranging in size from $100,000 to $500,000.
- Investment Period: 4 years (plus follow-ons).
- Fund Term: 10 years (unless extended in accordance with the partnership deed).
